Johnson & Johnson’s Shockwave Medical strengthened its position in the intravascular lithotripsy (IVL) market.
The New Brunswick, NJ-based company said earlier this week that it was launching the Shockwave Javelin Peripheral IVL Catheter, a platform designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD).
privacy policy | terms of use | contact us | advertise | pharma blogs | facebook | twitter
Copyright © 2025,